nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.167	0.74	CrCtD
Methyltestosterone—Prednisone—prostate cancer	0.0586	0.26	CrCtD
Methyltestosterone—breast cancer—Estrone—prostate cancer	0.0526	0.245	CpDpCtD
Methyltestosterone—breast cancer—Estradiol valerate/Dienogest—prostate cancer	0.0526	0.245	CpDpCtD
Methyltestosterone—SHBG—prostate cancer	0.0452	0.338	CbGaD
Methyltestosterone—breast cancer—Conjugated Estrogens—prostate cancer	0.0399	0.185	CpDpCtD
Methyltestosterone—breast cancer—Estradiol—prostate cancer	0.0399	0.185	CpDpCtD
Methyltestosterone—AR—prostate cancer	0.0396	0.297	CbGaD
Methyltestosterone—CYP19A1—prostate cancer	0.0331	0.248	CbGaD
Methyltestosterone—breast cancer—Ethinyl Estradiol—prostate cancer	0.0302	0.14	CpDpCtD
Methyltestosterone—AR—Nilutamide—prostate cancer	0.0225	0.126	CbGbCtD
Methyltestosterone—AR—Bicalutamide—prostate cancer	0.0225	0.126	CbGbCtD
Methyltestosterone—AR—Flutamide—prostate cancer	0.0187	0.104	CbGbCtD
Methyltestosterone—SHBG—Estrone—prostate cancer	0.0161	0.09	CbGbCtD
Methyltestosterone—CYP3A4—prostate cancer	0.0156	0.117	CbGaD
Methyltestosterone—SHBG—Ethinyl Estradiol—prostate cancer	0.0144	0.0802	CbGbCtD
Methyltestosterone—Testosterone—Abiraterone—prostate cancer	0.0121	0.0681	CrCrCtD
Methyltestosterone—Ethinyl Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.011	0.062	CrCrCtD
Methyltestosterone—Trilostane—Estradiol—prostate cancer	0.0103	0.058	CrCrCtD
Methyltestosterone—Mestranol—Estramustine—prostate cancer	0.00985	0.0553	CrCrCtD
Methyltestosterone—Ethinyl Estradiol—Estramustine—prostate cancer	0.00939	0.0527	CrCrCtD
Methyltestosterone—SHBG—Estradiol—prostate cancer	0.00926	0.0517	CbGbCtD
Methyltestosterone—Formestane—Estrone—prostate cancer	0.00824	0.0463	CrCrCtD
Methyltestosterone—Mestranol—Estrone—prostate cancer	0.00783	0.044	CrCrCtD
Methyltestosterone—AR—Estradiol—prostate cancer	0.00775	0.0432	CbGbCtD
Methyltestosterone—Drostanolone—Estradiol—prostate cancer	0.00747	0.0419	CrCrCtD
Methyltestosterone—Ethinyl Estradiol—Estrone—prostate cancer	0.00746	0.0419	CrCrCtD
Methyltestosterone—SLCO1A2—Estrone—prostate cancer	0.00739	0.0413	CbGbCtD
Methyltestosterone—Formestane—Conjugated Estrogens—prostate cancer	0.00726	0.0407	CrCrCtD
Methyltestosterone—Mestranol—Conjugated Estrogens—prostate cancer	0.00689	0.0387	CrCrCtD
Methyltestosterone—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.00683	0.0383	CrCrCtD
Methyltestosterone—Ethinyl Estradiol—Conjugated Estrogens—prostate cancer	0.00656	0.0369	CrCrCtD
Methyltestosterone—Etonogestrel—Ethinyl Estradiol—prostate cancer	0.00644	0.0362	CrCrCtD
Methyltestosterone—Mestranol—Estradiol—prostate cancer	0.00593	0.0333	CrCrCtD
Methyltestosterone—Mestranol—Ethinyl Estradiol—prostate cancer	0.00579	0.0325	CrCrCtD
Methyltestosterone—Ethinyl Estradiol—Estradiol—prostate cancer	0.00565	0.0317	CrCrCtD
Methyltestosterone—ALB—Abiraterone—prostate cancer	0.00528	0.0295	CbGbCtD
Methyltestosterone—Testolactone—Estrone—prostate cancer	0.00515	0.0289	CrCrCtD
Methyltestosterone—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.00505	0.0283	CrCrCtD
Methyltestosterone—Testosterone—Estramustine—prostate cancer	0.00504	0.0283	CrCrCtD
Methyltestosterone—SLCO1A2—Conjugated Estrogens—prostate cancer	0.00484	0.027	CbGbCtD
Methyltestosterone—Danazol—Ethinyl Estradiol—prostate cancer	0.00466	0.0262	CrCrCtD
Methyltestosterone—SLCO1A2—Estradiol—prostate cancer	0.00425	0.0237	CbGbCtD
Methyltestosterone—SLC22A8—Conjugated Estrogens—prostate cancer	0.00421	0.0235	CbGbCtD
Methyltestosterone—Norethindrone—Ethinyl Estradiol—prostate cancer	0.00405	0.0228	CrCrCtD
Methyltestosterone—Testosterone—Estrone—prostate cancer	0.004	0.0225	CrCrCtD
Methyltestosterone—CYP2B6—Estrone—prostate cancer	0.0039	0.0218	CbGbCtD
Methyltestosterone—ALB—Estrone—prostate cancer	0.00382	0.0213	CbGbCtD
Methyltestosterone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0038	0.0212	CbGbCtD
Methyltestosterone—SLC22A8—Estradiol—prostate cancer	0.0037	0.0206	CbGbCtD
Methyltestosterone—SLCO1A2—Prednisone—prostate cancer	0.00365	0.0204	CbGbCtD
Methyltestosterone—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00347	0.0194	CbGbCtD
Methyltestosterone—Testosterone—Estradiol—prostate cancer	0.00303	0.017	CrCrCtD
Methyltestosterone—ALB—Estradiol—prostate cancer	0.00219	0.0122	CbGbCtD
Methyltestosterone—CYP3A4—Bicalutamide—prostate cancer	0.002	0.0112	CbGbCtD
Methyltestosterone—Potassium Canrenoate—Prednisone—prostate cancer	0.00194	0.0109	CrCrCtD
Methyltestosterone—ALB—Prednisone—prostate cancer	0.00189	0.0105	CbGbCtD
Methyltestosterone—CYP3A4—Estramustine—prostate cancer	0.00186	0.0104	CbGbCtD
Methyltestosterone—SHBG—semen—prostate cancer	0.00171	0.148	CbGeAlD
Methyltestosterone—CYP3A4—Flutamide—prostate cancer	0.00166	0.00924	CbGbCtD
Methyltestosterone—CYP3A4—Abiraterone—prostate cancer	0.00166	0.00924	CbGbCtD
Methyltestosterone—Danazol—Prednisone—prostate cancer	0.00164	0.00919	CrCrCtD
Methyltestosterone—Hydrocortamate—Prednisone—prostate cancer	0.00142	0.00799	CrCrCtD
Methyltestosterone—CYP19A1—semen—prostate cancer	0.00138	0.12	CbGeAlD
Methyltestosterone—Cortisone acetate—Prednisone—prostate cancer	0.00138	0.00774	CrCrCtD
Methyltestosterone—Testolactone—Prednisone—prostate cancer	0.00134	0.00751	CrCrCtD
Methyltestosterone—AR—penis—prostate cancer	0.00128	0.112	CbGeAlD
Methyltestosterone—CYP3A4—Cabazitaxel—prostate cancer	0.00122	0.00684	CbGbCtD
Methyltestosterone—AR—semen—prostate cancer	0.00122	0.106	CbGeAlD
Methyltestosterone—Fludrocortisone—Prednisone—prostate cancer	0.0012	0.00673	CrCrCtD
Methyltestosterone—CYP3A4—Estrone—prostate cancer	0.0012	0.00668	CbGbCtD
Methyltestosterone—Loteprednol—Prednisone—prostate cancer	0.00111	0.00625	CrCrCtD
Methyltestosterone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00107	0.00596	CbGbCtD
Methyltestosterone—Prednisolone—Prednisone—prostate cancer	0.00102	0.00572	CrCrCtD
Methyltestosterone—CYP2B6—Doxorubicin—prostate cancer	0.000997	0.00556	CbGbCtD
Methyltestosterone—Hydrocortisone—Prednisone—prostate cancer	0.000977	0.00549	CrCrCtD
Methyltestosterone—SLC22A8—urine—prostate cancer	0.000944	0.0822	CbGeAlD
Methyltestosterone—Embolism venous—Estramustine—prostate cancer	0.000832	0.0292	CcSEcCtD
Methyltestosterone—CYP3A4—Conjugated Estrogens—prostate cancer	0.000783	0.00437	CbGbCtD
Methyltestosterone—Venous thromboembolism—Ethinyl Estradiol—prostate cancer	0.000773	0.0272	CcSEcCtD
Methyltestosterone—CYP3A4—Mitoxantrone—prostate cancer	0.000712	0.00397	CbGbCtD
Methyltestosterone—Hirsutism—Estrone—prostate cancer	0.00069	0.0242	CcSEcCtD
Methyltestosterone—CYP3A4—Estradiol—prostate cancer	0.000688	0.00384	CbGbCtD
Methyltestosterone—Hirsutism—Estradiol valerate/Dienogest—prostate cancer	0.000602	0.0211	CcSEcCtD
Methyltestosterone—CYP3A4—Prednisone—prostate cancer	0.000591	0.0033	CbGbCtD
Methyltestosterone—Clotting—Conjugated Estrogens—prostate cancer	0.000519	0.0182	CcSEcCtD
Methyltestosterone—CYP3A4—urine—prostate cancer	0.000468	0.0407	CbGeAlD
Methyltestosterone—Blood cholesterol increased—Goserelin—prostate cancer	0.000464	0.0163	CcSEcCtD
Methyltestosterone—Hirsutism—Bicalutamide—prostate cancer	0.000463	0.0162	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Estrone—prostate cancer	0.000456	0.016	CcSEcCtD
Methyltestosterone—Embolism venous—Ethinyl Estradiol—prostate cancer	0.00045	0.0158	CcSEcCtD
Methyltestosterone—CYP3A4—Etoposide—prostate cancer	0.000449	0.00251	CbGbCtD
Methyltestosterone—SHBG—prostate gland—prostate cancer	0.000427	0.0372	CbGeAlD
Methyltestosterone—Jaundice cholestatic—Flutamide—prostate cancer	0.000422	0.0148	CcSEcCtD
Methyltestosterone—Clotting—Estradiol—prostate cancer	0.000415	0.0146	CcSEcCtD
Methyltestosterone—CYP3A4—Docetaxel—prostate cancer	0.000411	0.00229	CbGbCtD
Methyltestosterone—Jaundice cholestatic—Estradiol valerate/Dienogest—prostate cancer	0.000398	0.014	CcSEcCtD
Methyltestosterone—Polycythaemia—Prednisone—prostate cancer	0.000377	0.0132	CcSEcCtD
Methyltestosterone—Gynaecomastia—Estramustine—prostate cancer	0.000376	0.0132	CcSEcCtD
Methyltestosterone—Embolism venous—Conjugated Estrogens—prostate cancer	0.000367	0.0129	CcSEcCtD
Methyltestosterone—CYP19A1—prostate gland—prostate cancer	0.000347	0.0301	CbGeAlD
Methyltestosterone—SLC22A8—prostate gland—prostate cancer	0.000339	0.0295	CbGeAlD
Methyltestosterone—Gynaecomastia—Nilutamide—prostate cancer	0.000333	0.0117	CcSEcCtD
Methyltestosterone—Gynaecomastia—Flutamide—prostate cancer	0.000332	0.0117	CcSEcCtD
Methyltestosterone—Libido decreased—Estramustine—prostate cancer	0.000329	0.0115	CcSEcCtD
Methyltestosterone—Hirsutism—Goserelin—prostate cancer	0.000322	0.0113	CcSEcCtD
Methyltestosterone—Hirsutism—Conjugated Estrogens—prostate cancer	0.000319	0.0112	CcSEcCtD
Methyltestosterone—Oligospermia—Epirubicin—prostate cancer	0.000307	0.0108	CcSEcCtD
Methyltestosterone—AR—prostate gland—prostate cancer	0.000307	0.0267	CbGeAlD
Methyltestosterone—CYP3A4—Doxorubicin—prostate cancer	0.000306	0.00171	CbGbCtD
Methyltestosterone—Disturbance in sexual arousal—Estramustine—prostate cancer	0.000302	0.0106	CcSEcCtD
Methyltestosterone—Gynaecomastia—Degarelix—prostate cancer	0.000298	0.0105	CcSEcCtD
Methyltestosterone—Embolism venous—Estradiol—prostate cancer	0.000294	0.0103	CcSEcCtD
Methyltestosterone—Libido decreased—Nilutamide—prostate cancer	0.000292	0.0102	CcSEcCtD
Methyltestosterone—Libido decreased—Flutamide—prostate cancer	0.00029	0.0102	CcSEcCtD
Methyltestosterone—Oligospermia—Doxorubicin—prostate cancer	0.000284	0.00999	CcSEcCtD
Methyltestosterone—Libido decreased—Estradiol valerate/Dienogest—prostate cancer	0.000274	0.00962	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Nilutamide—prostate cancer	0.000268	0.00942	CcSEcCtD
Methyltestosterone—Menstruation irregular—Estradiol—prostate cancer	0.000268	0.00941	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Flutamide—prostate cancer	0.000267	0.00938	CcSEcCtD
Methyltestosterone—Libido decreased—Degarelix—prostate cancer	0.00026	0.00915	CcSEcCtD
Methyltestosterone—AR—seminal vesicle—prostate cancer	0.000259	0.0226	CbGeAlD
Methyltestosterone—Amenorrhoea—Ethinyl Estradiol—prostate cancer	0.000259	0.00908	CcSEcCtD
Methyltestosterone—Hirsutism—Estradiol—prostate cancer	0.000255	0.00896	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Estradiol valerate/Dienogest—prostate cancer	0.000252	0.00885	CcSEcCtD
Methyltestosterone—SLCO1A2—renal system—prostate cancer	0.000242	0.0211	CbGeAlD
Methyltestosterone—Gynaecomastia—Bicalutamide—prostate cancer	0.000241	0.00845	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Degarelix—prostate cancer	0.00024	0.00842	CcSEcCtD
Methyltestosterone—Azoospermia—Epirubicin—prostate cancer	0.000239	0.0084	CcSEcCtD
Methyltestosterone—Coagulopathy—Conjugated Estrogens—prostate cancer	0.000238	0.00836	CcSEcCtD
Methyltestosterone—SLC22A8—renal system—prostate cancer	0.000231	0.0201	CbGeAlD
Methyltestosterone—AR—epithelium—prostate cancer	0.000225	0.0196	CbGeAlD
Methyltestosterone—Azoospermia—Doxorubicin—prostate cancer	0.000221	0.00777	CcSEcCtD
Methyltestosterone—SHBG—bone marrow—prostate cancer	0.00022	0.0192	CbGeAlD
Methyltestosterone—Venous thromboembolism—Epirubicin—prostate cancer	0.000219	0.0077	CcSEcCtD
Methyltestosterone—Amenorrhoea—Goserelin—prostate cancer	0.000213	0.00748	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Conjugated Estrogens—prostate cancer	0.000211	0.00741	CcSEcCtD
Methyltestosterone—Amenorrhoea—Conjugated Estrogens—prostate cancer	0.000211	0.00741	CcSEcCtD
Methyltestosterone—Libido decreased—Bicalutamide—prostate cancer	0.00021	0.00739	CcSEcCtD
Methyltestosterone—AR—renal system—prostate cancer	0.000209	0.0182	CbGeAlD
Methyltestosterone—AR—urethra—prostate cancer	0.000205	0.0179	CbGeAlD
Methyltestosterone—Venous thromboembolism—Doxorubicin—prostate cancer	0.000203	0.00712	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Bicalutamide—prostate cancer	0.000194	0.0068	CcSEcCtD
Methyltestosterone—Coagulopathy—Estradiol—prostate cancer	0.00019	0.00669	CcSEcCtD
Methyltestosterone—SHBG—testis—prostate cancer	0.000188	0.0164	CbGeAlD
Methyltestosterone—Alopecia—Estramustine—prostate cancer	0.000186	0.00654	CcSEcCtD
Methyltestosterone—Angiopathy—Abiraterone—prostate cancer	0.000186	0.00652	CcSEcCtD
Methyltestosterone—Libido decreased—Ethinyl Estradiol—prostate cancer	0.000178	0.00625	CcSEcCtD
Methyltestosterone—Menstruation irregular—Docetaxel—prostate cancer	0.000173	0.00606	CcSEcCtD
Methyltestosterone—Amenorrhoea—Estradiol—prostate cancer	0.000169	0.00593	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Estradiol—prostate cancer	0.000169	0.00593	CcSEcCtD
Methyltestosterone—Gynaecomastia—Goserelin—prostate cancer	0.000167	0.00588	CcSEcCtD
Methyltestosterone—Trilostane—HSD3B1—prostate cancer	0.000166	0.097	CrCbGaD
Methyltestosterone—Alopecia—Nilutamide—prostate cancer	0.000165	0.0058	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Ethinyl Estradiol—prostate cancer	0.000164	0.00575	CcSEcCtD
Methyltestosterone—Embolism venous—Prednisone—prostate cancer	0.000163	0.00573	CcSEcCtD
Methyltestosterone—Hirsutism—Capecitabine—prostate cancer	0.000159	0.00559	CcSEcCtD
Methyltestosterone—Amenorrhoea—Mitoxantrone—prostate cancer	0.000157	0.00552	CcSEcCtD
Methyltestosterone—SLCO1A2—testis—prostate cancer	0.000156	0.0136	CbGeAlD
Methyltestosterone—Anxiety—Estramustine—prostate cancer	0.000156	0.00547	CcSEcCtD
Methyltestosterone—ALB—testis—prostate cancer	0.000156	0.0135	CbGeAlD
Methyltestosterone—CYP19A1—testis—prostate cancer	0.000153	0.0133	CbGeAlD
Methyltestosterone—CYP2B6—renal system—prostate cancer	0.000152	0.0132	CbGeAlD
Methyltestosterone—Angiopathy—Degarelix—prostate cancer	0.000152	0.00532	CcSEcCtD
Methyltestosterone—Menstruation irregular—Prednisone—prostate cancer	0.000149	0.00522	CcSEcCtD
Methyltestosterone—Alopecia—Degarelix—prostate cancer	0.000148	0.00519	CcSEcCtD
Methyltestosterone—Libido decreased—Goserelin—prostate cancer	0.000146	0.00514	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Estrone—prostate cancer	0.000143	0.00502	CcSEcCtD
Methyltestosterone—Angiopathy—Cabazitaxel—prostate cancer	0.000143	0.00502	CcSEcCtD
Methyltestosterone—Hirsutism—Prednisone—prostate cancer	0.000142	0.00498	CcSEcCtD
Methyltestosterone—Alopecia—Cabazitaxel—prostate cancer	0.000139	0.00488	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Conjugated Estrogens—prostate cancer	0.000139	0.00488	CcSEcCtD
Methyltestosterone—Anxiety—Flutamide—prostate cancer	0.000138	0.00483	CcSEcCtD
Methyltestosterone—Haemoglobin—Bicalutamide—prostate cancer	0.000136	0.00477	CcSEcCtD
Methyltestosterone—AR—testis—prostate cancer	0.000135	0.0118	CbGeAlD
Methyltestosterone—Haemorrhage—Bicalutamide—prostate cancer	0.000135	0.00474	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Goserelin—prostate cancer	0.000135	0.00473	CcSEcCtD
Methyltestosterone—Gynaecomastia—Estradiol—prostate cancer	0.000133	0.00466	CcSEcCtD
Methyltestosterone—Anxiety—Estradiol valerate/Dienogest—prostate cancer	0.00013	0.00456	CcSEcCtD
Methyltestosterone—Embolism venous—Epirubicin—prostate cancer	0.000128	0.00448	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.000125	0.00439	CcSEcCtD
Methyltestosterone—Angiopathy—Bicalutamide—prostate cancer	0.000123	0.0043	CcSEcCtD
Methyltestosterone—Paraesthesia—Nilutamide—prostate cancer	0.000119	0.00419	CcSEcCtD
Methyltestosterone—Alopecia—Bicalutamide—prostate cancer	0.000119	0.00419	CcSEcCtD
Methyltestosterone—Coagulopathy—Capecitabine—prostate cancer	0.000119	0.00417	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Degarelix—prostate cancer	0.000119	0.00417	CcSEcCtD
Methyltestosterone—Embolism venous—Doxorubicin—prostate cancer	0.000118	0.00415	CcSEcCtD
Methyltestosterone—Anxiety—Cabazitaxel—prostate cancer	0.000116	0.00408	CcSEcCtD
Methyltestosterone—Libido decreased—Estradiol—prostate cancer	0.000116	0.00408	CcSEcCtD
Methyltestosterone—Haemoglobin—Ethinyl Estradiol—prostate cancer	0.000115	0.00403	CcSEcCtD
Methyltestosterone—CYP3A4—renal system—prostate cancer	0.000115	0.00996	CbGeAlD
Methyltestosterone—Haemorrhage—Ethinyl Estradiol—prostate cancer	0.000114	0.00401	CcSEcCtD
Methyltestosterone—ALB—lymph node—prostate cancer	0.000113	0.00981	CbGeAlD
Methyltestosterone—Trilostane—HSD3B2—prostate cancer	0.000112	0.0655	CrCbGaD
Methyltestosterone—Anaphylactoid reaction—Estradiol—prostate cancer	0.000111	0.00391	CcSEcCtD
Methyltestosterone—CYP19A1—lymph node—prostate cancer	0.000111	0.00963	CbGeAlD
Methyltestosterone—Amenorrhoea—Docetaxel—prostate cancer	0.000109	0.00382	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Estradiol—prostate cancer	0.000107	0.00375	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Mitoxantrone—prostate cancer	0.000104	0.00364	CcSEcCtD
Methyltestosterone—Angiopathy—Ethinyl Estradiol—prostate cancer	0.000104	0.00364	CcSEcCtD
Methyltestosterone—Alopecia—Ethinyl Estradiol—prostate cancer	0.000101	0.00354	CcSEcCtD
Methyltestosterone—Paraesthesia—Cabazitaxel—prostate cancer	0.0001	0.00353	CcSEcCtD
Methyltestosterone—Anxiety—Bicalutamide—prostate cancer	9.97e-05	0.0035	CcSEcCtD
Methyltestosterone—CYP2B6—testis—prostate cancer	9.8e-05	0.00853	CbGeAlD
Methyltestosterone—AR—lymph node—prostate cancer	9.8e-05	0.00852	CbGeAlD
Methyltestosterone—Haemoglobin—Goserelin—prostate cancer	9.44e-05	0.00332	CcSEcCtD
Methyltestosterone—Haemorrhage—Goserelin—prostate cancer	9.39e-05	0.0033	CcSEcCtD
Methyltestosterone—Headache—Estramustine—prostate cancer	9.38e-05	0.0033	CcSEcCtD
Methyltestosterone—Amenorrhoea—Prednisone—prostate cancer	9.37e-05	0.00329	CcSEcCtD
Methyltestosterone—Headache—Estrone—prostate cancer	8.96e-05	0.00315	CcSEcCtD
Methyltestosterone—Nausea—Estramustine—prostate cancer	8.9e-05	0.00312	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Etoposide—prostate cancer	8.62e-05	0.00303	CcSEcCtD
Methyltestosterone—Paraesthesia—Bicalutamide—prostate cancer	8.61e-05	0.00303	CcSEcCtD
Methyltestosterone—Angiopathy—Goserelin—prostate cancer	8.52e-05	0.00299	CcSEcCtD
Methyltestosterone—Nausea—Estrone—prostate cancer	8.5e-05	0.00298	CcSEcCtD
Methyltestosterone—Angiopathy—Conjugated Estrogens—prostate cancer	8.44e-05	0.00296	CcSEcCtD
Methyltestosterone—Anxiety—Ethinyl Estradiol—prostate cancer	8.43e-05	0.00296	CcSEcCtD
Methyltestosterone—Headache—Nilutamide—prostate cancer	8.33e-05	0.00292	CcSEcCtD
Methyltestosterone—Alopecia—Goserelin—prostate cancer	8.3e-05	0.00292	CcSEcCtD
Methyltestosterone—Headache—Flutamide—prostate cancer	8.29e-05	0.00291	CcSEcCtD
Methyltestosterone—Alopecia—Conjugated Estrogens—prostate cancer	8.22e-05	0.00289	CcSEcCtD
Methyltestosterone—Nausea—Nilutamide—prostate cancer	7.89e-05	0.00277	CcSEcCtD
Methyltestosterone—Nausea—Flutamide—prostate cancer	7.86e-05	0.00276	CcSEcCtD
Methyltestosterone—Headache—Estradiol valerate/Dienogest—prostate cancer	7.82e-05	0.00275	CcSEcCtD
Methyltestosterone—Haemoglobin—Estradiol—prostate cancer	7.48e-05	0.00263	CcSEcCtD
Methyltestosterone—Haemorrhage—Estradiol—prostate cancer	7.45e-05	0.00262	CcSEcCtD
Methyltestosterone—Headache—Degarelix—prostate cancer	7.44e-05	0.00261	CcSEcCtD
Methyltestosterone—Nausea—Estradiol valerate/Dienogest—prostate cancer	7.42e-05	0.0026	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Epirubicin—prostate cancer	7.33e-05	0.00257	CcSEcCtD
Methyltestosterone—Amenorrhoea—Epirubicin—prostate cancer	7.33e-05	0.00257	CcSEcCtD
Methyltestosterone—Libido decreased—Capecitabine—prostate cancer	7.24e-05	0.00254	CcSEcCtD
Methyltestosterone—Nausea—Degarelix—prostate cancer	7.05e-05	0.00248	CcSEcCtD
Methyltestosterone—Headache—Cabazitaxel—prostate cancer	7.01e-05	0.00246	CcSEcCtD
Methyltestosterone—Haemoglobin—Mitoxantrone—prostate cancer	6.97e-05	0.00245	CcSEcCtD
Methyltestosterone—Haemorrhage—Mitoxantrone—prostate cancer	6.94e-05	0.00244	CcSEcCtD
Methyltestosterone—Anxiety—Goserelin—prostate cancer	6.94e-05	0.00244	CcSEcCtD
Methyltestosterone—Anxiety—Conjugated Estrogens—prostate cancer	6.87e-05	0.00241	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Doxorubicin—prostate cancer	6.78e-05	0.00238	CcSEcCtD
Methyltestosterone—Amenorrhoea—Doxorubicin—prostate cancer	6.78e-05	0.00238	CcSEcCtD
Methyltestosterone—Angiopathy—Estradiol—prostate cancer	6.76e-05	0.00237	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Goserelin—prostate cancer	6.67e-05	0.00234	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Capecitabine—prostate cancer	6.66e-05	0.00234	CcSEcCtD
Methyltestosterone—Nausea—Cabazitaxel—prostate cancer	6.64e-05	0.00233	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Conjugated Estrogens—prostate cancer	6.61e-05	0.00232	CcSEcCtD
Methyltestosterone—Alopecia—Estradiol—prostate cancer	6.58e-05	0.00231	CcSEcCtD
Methyltestosterone—Alopecia—Mitoxantrone—prostate cancer	6.13e-05	0.00215	CcSEcCtD
Methyltestosterone—Headache—Bicalutamide—prostate cancer	6.01e-05	0.00211	CcSEcCtD
Methyltestosterone—Paraesthesia—Goserelin—prostate cancer	5.99e-05	0.0021	CcSEcCtD
Methyltestosterone—Paraesthesia—Conjugated Estrogens—prostate cancer	5.94e-05	0.00208	CcSEcCtD
Methyltestosterone—Nausea—Bicalutamide—prostate cancer	5.7e-05	0.002	CcSEcCtD
Methyltestosterone—Anxiety—Estradiol—prostate cancer	5.5e-05	0.00193	CcSEcCtD
Methyltestosterone—Levonorgestrel—SRD5A1—prostate cancer	5.39e-05	0.0315	CrCbGaD
Methyltestosterone—Anaphylactic shock—Estradiol—prostate cancer	5.29e-05	0.00186	CcSEcCtD
Methyltestosterone—Angiopathy—Etoposide—prostate cancer	5.24e-05	0.00184	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	5.18e-05	0.0303	CrCbGaD
Methyltestosterone—Anxiety—Mitoxantrone—prostate cancer	5.12e-05	0.0018	CcSEcCtD
Methyltestosterone—Alopecia—Etoposide—prostate cancer	5.1e-05	0.00179	CcSEcCtD
Methyltestosterone—Headache—Ethinyl Estradiol—prostate cancer	5.08e-05	0.00178	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Mitoxantrone—prostate cancer	4.93e-05	0.00173	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Epirubicin—prostate cancer	4.83e-05	0.0017	CcSEcCtD
Methyltestosterone—Haemoglobin—Docetaxel—prostate cancer	4.82e-05	0.00169	CcSEcCtD
Methyltestosterone—Nausea—Ethinyl Estradiol—prostate cancer	4.82e-05	0.00169	CcSEcCtD
Methyltestosterone—Haemorrhage—Docetaxel—prostate cancer	4.8e-05	0.00168	CcSEcCtD
Methyltestosterone—Paraesthesia—Estradiol—prostate cancer	4.75e-05	0.00167	CcSEcCtD
Methyltestosterone—Haemoglobin—Capecitabine—prostate cancer	4.67e-05	0.00164	CcSEcCtD
Methyltestosterone—Haemorrhage—Capecitabine—prostate cancer	4.64e-05	0.00163	CcSEcCtD
Methyltestosterone—Stanozolol—AR—prostate cancer	4.5e-05	0.0263	CrCbGaD
Methyltestosterone—Anaphylactoid reaction—Doxorubicin—prostate cancer	4.47e-05	0.00157	CcSEcCtD
Methyltestosterone—Paraesthesia—Mitoxantrone—prostate cancer	4.43e-05	0.00155	CcSEcCtD
Methyltestosterone—Angiopathy—Docetaxel—prostate cancer	4.35e-05	0.00153	CcSEcCtD
Methyltestosterone—Alopecia—Docetaxel—prostate cancer	4.24e-05	0.00149	CcSEcCtD
Methyltestosterone—Angiopathy—Capecitabine—prostate cancer	4.21e-05	0.00148	CcSEcCtD
Methyltestosterone—Headache—Goserelin—prostate cancer	4.18e-05	0.00147	CcSEcCtD
Methyltestosterone—Haemoglobin—Prednisone—prostate cancer	4.16e-05	0.00146	CcSEcCtD
Methyltestosterone—Ethinyl Estradiol—AOX1—prostate cancer	4.16e-05	0.0243	CrCbGaD
Methyltestosterone—Headache—Conjugated Estrogens—prostate cancer	4.14e-05	0.00145	CcSEcCtD
Methyltestosterone—Haemorrhage—Prednisone—prostate cancer	4.14e-05	0.00145	CcSEcCtD
Methyltestosterone—Alopecia—Capecitabine—prostate cancer	4.1e-05	0.00144	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Etoposide—prostate cancer	4.1e-05	0.00144	CcSEcCtD
Methyltestosterone—Oxandrolone—AR—prostate cancer	4.06e-05	0.0237	CrCbGaD
Methyltestosterone—Nausea—Goserelin—prostate cancer	3.96e-05	0.00139	CcSEcCtD
Methyltestosterone—Nausea—Conjugated Estrogens—prostate cancer	3.93e-05	0.00138	CcSEcCtD
Methyltestosterone—Angiopathy—Prednisone—prostate cancer	3.75e-05	0.00132	CcSEcCtD
Methyltestosterone—Paraesthesia—Etoposide—prostate cancer	3.68e-05	0.00129	CcSEcCtD
Methyltestosterone—Alopecia—Prednisone—prostate cancer	3.66e-05	0.00128	CcSEcCtD
Methyltestosterone—Trilostane—ESR2—prostate cancer	3.54e-05	0.0207	CrCbGaD
Methyltestosterone—Anxiety—Capecitabine—prostate cancer	3.43e-05	0.0012	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Docetaxel—prostate cancer	3.41e-05	0.0012	CcSEcCtD
Methyltestosterone—Headache—Estradiol—prostate cancer	3.31e-05	0.00116	CcSEcCtD
Methyltestosterone—Haemoglobin—Epirubicin—prostate cancer	3.25e-05	0.00114	CcSEcCtD
Methyltestosterone—Haemorrhage—Epirubicin—prostate cancer	3.24e-05	0.00114	CcSEcCtD
Methyltestosterone—Nausea—Estradiol—prostate cancer	3.14e-05	0.0011	CcSEcCtD
Methyltestosterone—Headache—Mitoxantrone—prostate cancer	3.09e-05	0.00108	CcSEcCtD
Methyltestosterone—Drostanolone—SHBG—prostate cancer	3.08e-05	0.018	CrCbGaD
Methyltestosterone—Paraesthesia—Docetaxel—prostate cancer	3.06e-05	0.00107	CcSEcCtD
Methyltestosterone—Anxiety—Prednisone—prostate cancer	3.05e-05	0.00107	CcSEcCtD
Methyltestosterone—Haemoglobin—Doxorubicin—prostate cancer	3.01e-05	0.00106	CcSEcCtD
Methyltestosterone—Haemorrhage—Doxorubicin—prostate cancer	2.99e-05	0.00105	CcSEcCtD
Methyltestosterone—Paraesthesia—Capecitabine—prostate cancer	2.96e-05	0.00104	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Prednisone—prostate cancer	2.94e-05	0.00103	CcSEcCtD
Methyltestosterone—Angiopathy—Epirubicin—prostate cancer	2.94e-05	0.00103	CcSEcCtD
Methyltestosterone—Nausea—Mitoxantrone—prostate cancer	2.93e-05	0.00103	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	2.87e-05	0.0168	CrCbGaD
Methyltestosterone—Alopecia—Epirubicin—prostate cancer	2.86e-05	0.001	CcSEcCtD
Methyltestosterone—Angiopathy—Doxorubicin—prostate cancer	2.72e-05	0.000954	CcSEcCtD
Methyltestosterone—Testosterone Propionate—CYP17A1—prostate cancer	2.71e-05	0.0158	CrCbGaD
Methyltestosterone—Drostanolone—AR—prostate cancer	2.7e-05	0.0158	CrCbGaD
Methyltestosterone—Hydrocortisone—ANXA1—prostate cancer	2.66e-05	0.0155	CrCbGaD
Methyltestosterone—Alopecia—Doxorubicin—prostate cancer	2.65e-05	0.000929	CcSEcCtD
Methyltestosterone—Paraesthesia—Prednisone—prostate cancer	2.64e-05	0.000927	CcSEcCtD
Methyltestosterone—Testosterone—CYP3A43—prostate cancer	2.59e-05	0.0151	CrCbGaD
Methyltestosterone—Etonogestrel—SHBG—prostate cancer	2.58e-05	0.0151	CrCbGaD
Methyltestosterone—Headache—Etoposide—prostate cancer	2.57e-05	0.000902	CcSEcCtD
Methyltestosterone—Testolactone—CYP19A1—prostate cancer	2.53e-05	0.0148	CrCbGaD
Methyltestosterone—Nausea—Etoposide—prostate cancer	2.44e-05	0.000855	CcSEcCtD
Methyltestosterone—Anxiety—Epirubicin—prostate cancer	2.39e-05	0.000839	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Epirubicin—prostate cancer	2.3e-05	0.000807	CcSEcCtD
Methyltestosterone—Drostanolone—CYP19A1—prostate cancer	2.26e-05	0.0132	CrCbGaD
Methyltestosterone—Allylestrenol—ESR1—prostate cancer	2.24e-05	0.0131	CrCbGaD
Methyltestosterone—Anxiety—Doxorubicin—prostate cancer	2.21e-05	0.000776	CcSEcCtD
Methyltestosterone—Testosterone Propionate—COMT—prostate cancer	2.21e-05	0.0129	CrCbGaD
Methyltestosterone—Mestranol—ESR1—prostate cancer	2.18e-05	0.0127	CrCbGaD
Methyltestosterone—Trilostane—ESR1—prostate cancer	2.18e-05	0.0127	CrCbGaD
Methyltestosterone—Headache—Docetaxel—prostate cancer	2.13e-05	0.00075	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Doxorubicin—prostate cancer	2.13e-05	0.000747	CcSEcCtD
Methyltestosterone—Headache—Capecitabine—prostate cancer	2.07e-05	0.000726	CcSEcCtD
Methyltestosterone—Paraesthesia—Epirubicin—prostate cancer	2.06e-05	0.000725	CcSEcCtD
Methyltestosterone—Nausea—Docetaxel—prostate cancer	2.02e-05	0.000711	CcSEcCtD
Methyltestosterone—Drospirenone—AR—prostate cancer	1.96e-05	0.0115	CrCbGaD
Methyltestosterone—Nausea—Capecitabine—prostate cancer	1.96e-05	0.000688	CcSEcCtD
Methyltestosterone—Paraesthesia—Doxorubicin—prostate cancer	1.91e-05	0.000671	CcSEcCtD
Methyltestosterone—Loteprednol—NR3C1—prostate cancer	1.87e-05	0.0109	CrCbGaD
Methyltestosterone—Eplerenone—CYP3A5—prostate cancer	1.86e-05	0.0109	CrCbGaD
Methyltestosterone—Fludrocortisone—AR—prostate cancer	1.85e-05	0.0108	CrCbGaD
Methyltestosterone—Headache—Prednisone—prostate cancer	1.84e-05	0.000647	CcSEcCtD
Methyltestosterone—Levonorgestrel—SHBG—prostate cancer	1.82e-05	0.0107	CrCbGaD
Methyltestosterone—Nausea—Prednisone—prostate cancer	1.75e-05	0.000613	CcSEcCtD
Methyltestosterone—Etonogestrel—ESR1—prostate cancer	1.74e-05	0.0102	CrCbGaD
Methyltestosterone—Fluoxymesterone—SHBG—prostate cancer	1.74e-05	0.0102	CrCbGaD
Methyltestosterone—Medrysone—NR3C1—prostate cancer	1.72e-05	0.0101	CrCbGaD
Methyltestosterone—Ethinyl Estradiol—ESR2—prostate cancer	1.69e-05	0.00985	CrCbGaD
Methyltestosterone—Danazol—SHBG—prostate cancer	1.66e-05	0.00971	CrCbGaD
Methyltestosterone—Testosterone Propionate—AR—prostate cancer	1.65e-05	0.00962	CrCbGaD
Methyltestosterone—Hydrocortamate—NR3C1—prostate cancer	1.6e-05	0.00938	CrCbGaD
Methyltestosterone—Levonorgestrel—AR—prostate cancer	1.6e-05	0.00935	CrCbGaD
Methyltestosterone—Spironolactone—SHBG—prostate cancer	1.59e-05	0.00931	CrCbGaD
Methyltestosterone—Cortisone acetate—NR3C1—prostate cancer	1.58e-05	0.00923	CrCbGaD
Methyltestosterone—Ethinyl Estradiol—SHBG—prostate cancer	1.54e-05	0.00899	CrCbGaD
Methyltestosterone—Fluoxymesterone—AR—prostate cancer	1.52e-05	0.00891	CrCbGaD
Methyltestosterone—Megestrol acetate—NR3C1—prostate cancer	1.52e-05	0.0089	CrCbGaD
Methyltestosterone—Medroxyprogesterone Acetate—SHBG—prostate cancer	1.49e-05	0.00872	CrCbGaD
Methyltestosterone—Norethindrone—SHBG—prostate cancer	1.48e-05	0.00864	CrCbGaD
Methyltestosterone—Danazol—AR—prostate cancer	1.46e-05	0.00852	CrCbGaD
Methyltestosterone—Headache—Epirubicin—prostate cancer	1.44e-05	0.000506	CcSEcCtD
Methyltestosterone—Spironolactone—AR—prostate cancer	1.4e-05	0.00816	CrCbGaD
Methyltestosterone—Nausea—Epirubicin—prostate cancer	1.37e-05	0.000479	CcSEcCtD
Methyltestosterone—Levonorgestrel—CYP19A1—prostate cancer	1.34e-05	0.00783	CrCbGaD
Methyltestosterone—Headache—Doxorubicin—prostate cancer	1.33e-05	0.000468	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—AR—prostate cancer	1.31e-05	0.00765	CrCbGaD
Methyltestosterone—Nausea—Doxorubicin—prostate cancer	1.26e-05	0.000444	CcSEcCtD
Methyltestosterone—Fludrocortisone—NR3C1—prostate cancer	1.25e-05	0.00732	CrCbGaD
Methyltestosterone—Progesterone—CYP17A1—prostate cancer	1.24e-05	0.00727	CrCbGaD
Methyltestosterone—Levonorgestrel—ESR1—prostate cancer	1.23e-05	0.0072	CrCbGaD
Methyltestosterone—Danazol—CYP19A1—prostate cancer	1.22e-05	0.00713	CrCbGaD
Methyltestosterone—Progesterone—SLC22A3—prostate cancer	1.19e-05	0.00693	CrCbGaD
Methyltestosterone—Norethindrone—CYP3A5—prostate cancer	1.18e-05	0.00688	CrCbGaD
Methyltestosterone—Fluoxymesterone—ESR1—prostate cancer	1.17e-05	0.00687	CrCbGaD
Methyltestosterone—Allylestrenol—CYP3A4—prostate cancer	1.14e-05	0.00667	CrCbGaD
Methyltestosterone—Danazol—ESR1—prostate cancer	1.12e-05	0.00656	CrCbGaD
Methyltestosterone—Testosterone—SLC22A3—prostate cancer	1.12e-05	0.00655	CrCbGaD
Methyltestosterone—Prednisolone—CYP2A6—prostate cancer	1.07e-05	0.00623	CrCbGaD
Methyltestosterone—Hydrocortisone—SHBG—prostate cancer	1.06e-05	0.00618	CrCbGaD
Methyltestosterone—Ethinyl Estradiol—ESR1—prostate cancer	1.04e-05	0.00607	CrCbGaD
Methyltestosterone—Fluoxymesterone—NR3C1—prostate cancer	1.03e-05	0.00604	CrCbGaD
Methyltestosterone—Medroxyprogesterone Acetate—ESR1—prostate cancer	1.01e-05	0.00589	CrCbGaD
Methyltestosterone—Spironolactone—NR3C1—prostate cancer	9.47e-06	0.00553	CrCbGaD
Methyltestosterone—Hydrocortamate—CYP3A4—prostate cancer	9.3e-06	0.00544	CrCbGaD
Methyltestosterone—Cortisone acetate—CYP3A4—prostate cancer	9.16e-06	0.00535	CrCbGaD
Methyltestosterone—Prednisone—NR3C1—prostate cancer	8.92e-06	0.00521	CrCbGaD
Methyltestosterone—Etonogestrel—CYP3A4—prostate cancer	8.89e-06	0.0052	CrCbGaD
Methyltestosterone—Medroxyprogesterone Acetate—NR3C1—prostate cancer	8.87e-06	0.00519	CrCbGaD
Methyltestosterone—Progesterone—SHBG—prostate cancer	8.62e-06	0.00504	CrCbGaD
Methyltestosterone—Progesterone—CYP1B1—prostate cancer	8.62e-06	0.00504	CrCbGaD
Methyltestosterone—Progesterone—SLC22A1—prostate cancer	8.5e-06	0.00497	CrCbGaD
Methyltestosterone—Hydrocortisone—CYP3A5—prostate cancer	8.42e-06	0.00492	CrCbGaD
Methyltestosterone—Prednisolone—NR3C1—prostate cancer	8.22e-06	0.00481	CrCbGaD
Methyltestosterone—Testosterone—SHBG—prostate cancer	8.15e-06	0.00476	CrCbGaD
Methyltestosterone—Testosterone—CYP1B1—prostate cancer	8.15e-06	0.00476	CrCbGaD
Methyltestosterone—Prednisone—CYP2C19—prostate cancer	8.13e-06	0.00475	CrCbGaD
Methyltestosterone—Eplerenone—CYP3A4—prostate cancer	8.04e-06	0.0047	CrCbGaD
Methyltestosterone—Testosterone—SLC22A1—prostate cancer	8.04e-06	0.0047	CrCbGaD
Methyltestosterone—Norethindrone—CYP2C19—prostate cancer	8.02e-06	0.00468	CrCbGaD
Methyltestosterone—Progesterone—AR—prostate cancer	7.56e-06	0.00442	CrCbGaD
Methyltestosterone—Drospirenone—PTGS2—prostate cancer	7.55e-06	0.00441	CrCbGaD
Methyltestosterone—Testosterone—AR—prostate cancer	7.14e-06	0.00417	CrCbGaD
Methyltestosterone—Progesterone—CYP3A5—prostate cancer	6.86e-06	0.00401	CrCbGaD
Methyltestosterone—Progesterone—CYP2A6—prostate cancer	6.64e-06	0.00388	CrCbGaD
Methyltestosterone—Testosterone—CYP3A5—prostate cancer	6.49e-06	0.00379	CrCbGaD
Methyltestosterone—Levonorgestrel—CYP3A4—prostate cancer	6.29e-06	0.00368	CrCbGaD
Methyltestosterone—Hydrocortisone—NR3C1—prostate cancer	6.29e-06	0.00368	CrCbGaD
Methyltestosterone—Testosterone—CYP19A1—prostate cancer	5.98e-06	0.00349	CrCbGaD
Methyltestosterone—Progesterone—ESR1—prostate cancer	5.82e-06	0.0034	CrCbGaD
Methyltestosterone—Danazol—CYP3A4—prostate cancer	5.73e-06	0.00335	CrCbGaD
Methyltestosterone—Ethinyl Estradiol—CYP3A4—prostate cancer	5.3e-06	0.0031	CrCbGaD
Methyltestosterone—Prednisone—CYP3A4—prostate cancer	5.17e-06	0.00302	CrCbGaD
Methyltestosterone—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	5.14e-06	0.00301	CrCbGaD
Methyltestosterone—Progesterone—NR3C1—prostate cancer	5.12e-06	0.00299	CrCbGaD
Methyltestosterone—Norethindrone—CYP3A4—prostate cancer	5.1e-06	0.00298	CrCbGaD
Methyltestosterone—Prednisolone—CYP3A4—prostate cancer	4.77e-06	0.00279	CrCbGaD
Methyltestosterone—Progesterone—CYP2C19—prostate cancer	4.67e-06	0.00273	CrCbGaD
Methyltestosterone—Progesterone—CYP1A1—prostate cancer	4.65e-06	0.00272	CrCbGaD
Methyltestosterone—Testosterone—CYP2C19—prostate cancer	4.42e-06	0.00258	CrCbGaD
Methyltestosterone—Testosterone—CYP1A1—prostate cancer	4.4e-06	0.00257	CrCbGaD
Methyltestosterone—Hydrocortisone—CYP3A4—prostate cancer	3.65e-06	0.00213	CrCbGaD
Methyltestosterone—Progesterone—CYP3A4—prostate cancer	2.97e-06	0.00174	CrCbGaD
Methyltestosterone—Testosterone—CYP3A4—prostate cancer	2.81e-06	0.00164	CrCbGaD
Methyltestosterone—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.69e-06	6.3e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.69e-06	6.3e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NAT1—prostate cancer	1.69e-06	6.3e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—DEGS1—prostate cancer	1.69e-06	6.3e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ITPR1—prostate cancer	1.68e-06	6.25e-05	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	1.65e-06	6.16e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.65e-06	6.15e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.65e-06	6.15e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PLCB2—prostate cancer	1.64e-06	6.13e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—LRP2—prostate cancer	1.64e-06	6.13e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP2C18—prostate cancer	1.64e-06	6.13e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP1A1—prostate cancer	1.64e-06	6.12e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ERCC2—prostate cancer	1.63e-06	6.07e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—HPGDS—prostate cancer	1.63e-06	6.07e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP2C19—prostate cancer	1.62e-06	6.03e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—P4HB—prostate cancer	1.61e-06	6.01e-05	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—CREBBP—prostate cancer	1.61e-06	6.01e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.61e-06	6.01e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—TYMS—prostate cancer	1.59e-06	5.91e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTT1—prostate cancer	1.58e-06	5.89e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ACHE—prostate cancer	1.58e-06	5.89e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SLC22A1—prostate cancer	1.57e-06	5.85e-05	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	1.57e-06	5.84e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTM1—prostate cancer	1.57e-06	5.84e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP2A6—prostate cancer	1.56e-06	5.82e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CG—prostate cancer	1.55e-06	5.78e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.55e-06	5.78e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—LPL—prostate cancer	1.54e-06	5.73e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—EGF—prostate cancer	1.53e-06	5.71e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—MTHFR—prostate cancer	1.53e-06	5.71e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SULT2A1—prostate cancer	1.53e-06	5.7e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—AKR1C3—prostate cancer	1.52e-06	5.66e-05	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—SERPINE1—prostate cancer	1.51e-06	5.63e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PRKACB—prostate cancer	1.51e-06	5.63e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—MED12—prostate cancer	1.5e-06	5.6e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PPARA—prostate cancer	1.5e-06	5.6e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP17A1—prostate cancer	1.5e-06	5.57e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GNG5—prostate cancer	1.49e-06	5.56e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP1A1—prostate cancer	1.49e-06	5.54e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ERCC2—prostate cancer	1.47e-06	5.49e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—CREBBP—prostate cancer	1.44e-06	5.36e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NCOA3—prostate cancer	1.44e-06	5.36e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—HPGD—prostate cancer	1.44e-06	5.35e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.44e-06	5.35e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NCOA2—prostate cancer	1.43e-06	5.31e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IGF1—prostate cancer	1.42e-06	5.29e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CAV1—prostate cancer	1.41e-06	5.27e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.41e-06	5.26e-05	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.41e-06	5.24e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—MTHFR—prostate cancer	1.38e-06	5.16e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—HPGDS—prostate cancer	1.37e-06	5.11e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CD—prostate cancer	1.36e-06	5.08e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP2C19—prostate cancer	1.36e-06	5.08e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SLC5A5—prostate cancer	1.36e-06	5.07e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PPARA—prostate cancer	1.36e-06	5.06e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.35e-06	5.03e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.35e-06	5.03e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SERPINE1—prostate cancer	1.35e-06	5.03e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTT1—prostate cancer	1.33e-06	4.96e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ACHE—prostate cancer	1.33e-06	4.96e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP2E1—prostate cancer	1.33e-06	4.95e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP2A6—prostate cancer	1.31e-06	4.9e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.31e-06	4.9e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—MTAP—prostate cancer	1.31e-06	4.9e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NQO1—prostate cancer	1.31e-06	4.89e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.31e-06	4.88e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—TH—prostate cancer	1.29e-06	4.82e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—NOS3—prostate cancer	1.29e-06	4.8e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CG—prostate cancer	1.29e-06	4.8e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.28e-06	4.77e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.28e-06	4.77e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP3A4—prostate cancer	1.28e-06	4.77e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—AKR1C3—prostate cancer	1.28e-06	4.77e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CAV1—prostate cancer	1.28e-06	4.76e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PRKACB—prostate cancer	1.27e-06	4.74e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP17A1—prostate cancer	1.26e-06	4.69e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP1B1—prostate cancer	1.26e-06	4.69e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—JAK2—prostate cancer	1.25e-06	4.66e-05	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.25e-06	4.64e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.24e-06	4.63e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ACSL4—prostate cancer	1.22e-06	4.55e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.22e-06	4.55e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.22e-06	4.55e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GGT1—prostate cancer	1.22e-06	4.54e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—INS—prostate cancer	1.22e-06	4.54e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NCOA1—prostate cancer	1.2e-06	4.47e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NCOA2—prostate cancer	1.2e-06	4.47e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CREBBP—prostate cancer	1.19e-06	4.45e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CB—prostate cancer	1.19e-06	4.43e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP19A1—prostate cancer	1.18e-06	4.41e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—UMPS—prostate cancer	1.17e-06	4.36e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ARG2—prostate cancer	1.17e-06	4.36e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PHGDH—prostate cancer	1.17e-06	4.36e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CG—prostate cancer	1.16e-06	4.34e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—LDHB—prostate cancer	1.15e-06	4.28e-05	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.15e-06	4.28e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SLC5A5—prostate cancer	1.14e-06	4.26e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—RXRA—prostate cancer	1.14e-06	4.26e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CD—prostate cancer	1.13e-06	4.22e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.13e-06	4.2e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP2E1—prostate cancer	1.12e-06	4.16e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NQO1—prostate cancer	1.11e-06	4.12e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—INS—prostate cancer	1.1e-06	4.1e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—COMT—prostate cancer	1.1e-06	4.1e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTP1—prostate cancer	1.1e-06	4.08e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IL2—prostate cancer	1.09e-06	4.07e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—TH—prostate cancer	1.09e-06	4.06e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TCN2—prostate cancer	1.09e-06	4.06e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—UCP3—prostate cancer	1.09e-06	4.06e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTA3—prostate cancer	1.09e-06	4.06e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PDHA1—prostate cancer	1.09e-06	4.06e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.08e-06	4.03e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CREBBP—prostate cancer	1.08e-06	4.02e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP3A4—prostate cancer	1.08e-06	4.02e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ITPR1—prostate cancer	1.08e-06	4.02e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.07e-06	4e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NOS3—prostate cancer	1.07e-06	3.98e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP1B1—prostate cancer	1.06e-06	3.95e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.04e-06	3.87e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.04e-06	3.87e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GGT1—prostate cancer	1.03e-06	3.82e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CD—prostate cancer	1.02e-06	3.81e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—TYMS—prostate cancer	1.02e-06	3.79e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NCOA1—prostate cancer	1.01e-06	3.77e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTM1—prostate cancer	1.01e-06	3.75e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP19A1—prostate cancer	9.96e-07	3.71e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTA4—prostate cancer	9.96e-07	3.71e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TBXAS1—prostate cancer	9.96e-07	3.71e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—LPL—prostate cancer	9.88e-07	3.68e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CB—prostate cancer	9.86e-07	3.68e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—EP300—prostate cancer	9.8e-07	3.65e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTGS2—prostate cancer	9.77e-07	3.64e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTA2—prostate cancer	9.71e-07	3.62e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NOS3—prostate cancer	9.66e-07	3.6e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—RXRA—prostate cancer	9.62e-07	3.58e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SULT1A1—prostate cancer	9.59e-07	3.57e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ABCG5—prostate cancer	9.59e-07	3.57e-05	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MYC—prostate cancer	9.57e-07	3.57e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP1A1—prostate cancer	9.54e-07	3.55e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SRC—prostate cancer	9.53e-07	3.55e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ERCC2—prostate cancer	9.46e-07	3.53e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTA1—prostate cancer	9.36e-07	3.49e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.35e-07	3.48e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFA—prostate cancer	9.28e-07	3.46e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—COMT—prostate cancer	9.26e-07	3.45e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTO1—prostate cancer	9.26e-07	3.45e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—HSD3B2—prostate cancer	9.26e-07	3.45e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NAT2—prostate cancer	9.26e-07	3.45e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTP1—prostate cancer	9.22e-07	3.43e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ITPR1—prostate cancer	9.07e-07	3.38e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.92e-07	3.32e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CB—prostate cancer	8.92e-07	3.32e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—MTHFR—prostate cancer	8.89e-07	3.31e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PLCB2—prostate cancer	8.88e-07	3.31e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—LRP2—prostate cancer	8.88e-07	3.31e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP2C18—prostate cancer	8.88e-07	3.31e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTGS2—prostate cancer	8.83e-07	3.29e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PPARA—prostate cancer	8.73e-07	3.25e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—P4HB—prostate cancer	8.71e-07	3.24e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—TYMS—prostate cancer	8.57e-07	3.19e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTEN—prostate cancer	8.52e-07	3.18e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TGFB1—prostate cancer	8.52e-07	3.17e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTM1—prostate cancer	8.47e-07	3.16e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC22A1—prostate cancer	8.47e-07	3.16e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—LPL—prostate cancer	8.31e-07	3.1e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SULT2A1—prostate cancer	8.25e-07	3.07e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CAV1—prostate cancer	8.2e-07	3.06e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—EP300—prostate cancer	8.13e-07	3.03e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—MED12—prostate cancer	8.12e-07	3.03e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GNG5—prostate cancer	8.05e-07	3e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP1A1—prostate cancer	8.03e-07	2.99e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ERCC2—prostate cancer	7.96e-07	2.97e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—KRAS—prostate cancer	7.89e-07	2.94e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NCOA3—prostate cancer	7.76e-07	2.89e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTEN—prostate cancer	7.7e-07	2.87e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—MTHFR—prostate cancer	7.49e-07	2.79e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CG—prostate cancer	7.47e-07	2.78e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—HPGDS—prostate cancer	7.4e-07	2.76e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.36e-07	2.74e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—EP300—prostate cancer	7.35e-07	2.74e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PPARA—prostate cancer	7.34e-07	2.74e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CA—prostate cancer	7.25e-07	2.7e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ACHE—prostate cancer	7.18e-07	2.68e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTT1—prostate cancer	7.18e-07	2.68e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP2A6—prostate cancer	7.1e-07	2.64e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—INS—prostate cancer	7.07e-07	2.64e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—prostate cancer	7.01e-07	2.61e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CREBBP—prostate cancer	6.93e-07	2.58e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CAV1—prostate cancer	6.91e-07	2.57e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.9e-07	2.57e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PRKACB—prostate cancer	6.87e-07	2.56e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.8e-07	2.53e-05	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—AKT1—prostate cancer	6.64e-07	2.47e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.6e-07	2.46e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CD—prostate cancer	6.57e-07	2.45e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NCOA2—prostate cancer	6.48e-07	2.41e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CG—prostate cancer	6.29e-07	2.34e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NOS3—prostate cancer	6.2e-07	2.31e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.18e-07	2.3e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.03e-07	2.25e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CA—prostate cancer	6.01e-07	2.24e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NQO1—prostate cancer	5.97e-07	2.22e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—INS—prostate cancer	5.95e-07	2.22e-05	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—AKT1—prostate cancer	5.92e-07	2.21e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TH—prostate cancer	5.88e-07	2.19e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CREBBP—prostate cancer	5.83e-07	2.17e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CB—prostate cancer	5.73e-07	2.13e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.72e-07	2.13e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTGS2—prostate cancer	5.67e-07	2.11e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GGT1—prostate cancer	5.54e-07	2.06e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CD—prostate cancer	5.53e-07	2.06e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NCOA1—prostate cancer	5.46e-07	2.03e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CA—prostate cancer	5.44e-07	2.03e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.38e-07	2e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NOS3—prostate cancer	5.22e-07	1.95e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—RXRA—prostate cancer	5.19e-07	1.93e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—COMT—prostate cancer	5e-07	1.86e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTP1—prostate cancer	4.98e-07	1.85e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTEN—prostate cancer	4.95e-07	1.84e-05	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—AKT1—prostate cancer	4.91e-07	1.83e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ITPR1—prostate cancer	4.9e-07	1.82e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CB—prostate cancer	4.82e-07	1.8e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTGS2—prostate cancer	4.78e-07	1.78e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—EP300—prostate cancer	4.72e-07	1.76e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TYMS—prostate cancer	4.63e-07	1.72e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTM1—prostate cancer	4.57e-07	1.7e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—LPL—prostate cancer	4.49e-07	1.67e-05	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—AKT1—prostate cancer	4.44e-07	1.65e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.34e-07	1.62e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ERCC2—prostate cancer	4.3e-07	1.6e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTEN—prostate cancer	4.16e-07	1.55e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—MTHFR—prostate cancer	4.04e-07	1.51e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—EP300—prostate cancer	3.97e-07	1.48e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PPARA—prostate cancer	3.96e-07	1.48e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CAV1—prostate cancer	3.73e-07	1.39e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CA—prostate cancer	3.49e-07	1.3e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.4e-07	1.27e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—INS—prostate cancer	3.21e-07	1.2e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CREBBP—prostate cancer	3.15e-07	1.17e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.99e-07	1.11e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CA—prostate cancer	2.94e-07	1.09e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—AKT1—prostate cancer	2.85e-07	1.06e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NOS3—prostate cancer	2.82e-07	1.05e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.6e-07	9.69e-06	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTGS2—prostate cancer	2.58e-07	9.61e-06	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—AKT1—prostate cancer	2.4e-07	8.94e-06	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTEN—prostate cancer	2.25e-07	8.38e-06	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—EP300—prostate cancer	2.14e-07	7.99e-06	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.59e-07	5.91e-06	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—AKT1—prostate cancer	1.3e-07	4.83e-06	CbGpPWpGaD
